41

References 1. van Mil JW, Frokjaer B, Tromp TF.

Changing a profession, influencing

community pharmacy. Pharm World Sci.

2004 Jun;26(3):1210-32;

2. Canadian Pharmacists Association.

Blueprint for Pharmacy: Designing the

Future Together . Accessed at

http://www.blueprintforpharmacy.ca

3. UK Department of Health. Pharmacy in

England: building on strengths - delivering

the future . Accessed at:

http://www.dh.gov.uk/en/Publicationsands

tatistics/Publications/PublicationsPolicyAn

dGuidance/DH_083815

4. White Paper Netherlands. Accessed at:

http://www.knmp.nl/over-de-

knmp/downloads/over-de-knmp/knmp-

vereniging/Witboek_eng.pdf

5. Consejo General de Colegios Oficiales de

Farmaceuticos. Compromiso Asistencial de

la Farmacia con el paciente y el SNS (2011).

Accessed at:

http://www.portalfarma.com/Profesionales/

DestacadosProfesionales/Paginas/Comprom

iso-Asistencial.aspx

6. The Pharmacy Guild of Australia.

Roadmap: Pharmacy Solutions . Accessed

at: http://www.guild.org.au/iwov-

resources/documents/The_Guild/PDFs/New

s%20and%20Events/Publications/The%20Ro

admap/Roadmap.pdf

7. Community Pharmacy Scotland. A vision

for Community Pharmacy in Scotland .

Accessed at:

http://www.communitypharmacyscotland.o

rg.uk/news,_policy_and_publications/news/

news_stories/a_vision_for_community_pha

rmacy_in_scotland.asp

8. World Health Organisation. Rational Use

of Medicines . Accessed at:

http://www.who.int/medicines/areas/ratio

nal_use/en/

9. Gurwitz JH, Field TS, Harrold LR et al

(2003). Incidence and preventability of

adverse drug events among older persons

in the ambulatory setting. JAMA,

5;2810(9):1107-16

10. Bootman JL, Harrison DL, Cox E (1997)

The Health Care Cost of Drug Related

Morbidity and Mortality in Nursing

Facilities. Archives of Internal Medicine,

157: 2099 96.

11. Johnson JA, Bootman JL (1995) Drug-

Related Morbidity And Mortality: A Cost-of-

Illness Model. Archives of Internal

Medicine, 155: 1949 56.

12. Manasse HR Jr. (1999) Medication Use in

an Imperfect World: Drug Misadventuring as

an Issue of Public Policy, Part 1. American

Journal of Hospital Pharmacy, 46:929 44.

13. Manasse HR Jr. (1999) Medication Use in

an Imperfect World: Drug Misadventuring

as an Issue of Public Policy, Part 2.

American Journal of Hospital Pharmacy,

46:1141 52.

14. Zed P. (2005) Drug-Related Visits to the

Emergency Department. Journal of

Pharmacy Practice, 19(5): 329-335

15. Forster AJ, Clark HD, Menard A et al.

(2004) Adverse events among medical